Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2022 Filed Dec 12, 2022 16:15 UTC |
Levit Alex C.Chief Legal Officer, Corp. Sec
|
PurchaseCommon Stock | 6,000 | $0.85 | $5,094.60 |
DisclosureSEC source: 0001842952-22-000110 · wf-form4_167087968272097.xml · nonDerivative · entry 1 Levit Alex C. · CIK 0001862840 · Chief Legal Officer, Corp. Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Read SEC document |
| August 19, 2022 Filed Aug 22, 2022 16:04 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
PurchaseCommon Stock | 13,000 | $1.85 | $24,064.30 |
DisclosureSEC source: 0001842952-22-000081 · wf-form4_166119862135485.xml · nonDerivative · entry 1 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,583 Read SEC document |
| August 17, 2022 Filed Aug 17, 2022 17:23 UTC |
Minai-Azary Jennifer LynnChief Financial Officer
|
PurchaseCommon Stock | 15,000 | $1.80 | $27,000.00 |
DisclosureSEC source: 0001842952-22-000079 · wf-form4_166077142478085.xml · nonDerivative · entry 1 Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 17:22 UTC |
Sahmoud TarekChief Medical Officer
|
PurchaseCommon Stock | 10,000 | $1.95 | $19,500.00 |
DisclosureSEC source: 0001842952-22-000077 · wf-form4_166077134963058.xml · nonDerivative · entry 1 Sahmoud Tarek · CIK 0001861811 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| August 12, 2022 Filed Aug 12, 2022 16:31 UTC |
Sahmoud TarekChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.96 | $0.00 |
DisclosureSEC source: 0001842952-22-000075 · wf-form4_166033625278582.xml · derivative · entry 1 Sahmoud Tarek · CIK 0001861811 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-08-11 F1 · derivative.exercise_date: The option vests and becomes exercisable over a two-year period. Fifty percent (50%) of the option vests and becomes exercisable on June 17, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining one year of the two-year period, subject to continued service with the Issuer. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 16:09 UTC |
BERMAN RICHARD JDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001842952-22-000058 · wf-form4_165428696068442.xml · derivative · entry 1 BERMAN RICHARD J · CIK 0001111620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: 1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:10 UTC |
Kantoff Philip W.Director
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001842952-22-000059 · wf-form4_165428700930146.xml · derivative · entry 1 Kantoff Philip W. · CIK 0001866025 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: 1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:10 UTC |
West LindaDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001842952-22-000060 · wf-form4_165428703516071.xml · derivative · entry 1 West Linda · CIK 0001805257 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: 1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:09 UTC |
Stacey Jennifer EvansDirector
|
GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001842952-22-000057 · wf-form4_165428693172276.xml · derivative · entry 1 Stacey Jennifer Evans · CIK 0001321326 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-01 F1 · derivative.exercise_date: 1.The option vests and becomes exercisable on the earlier of (i) June 2, 2023 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2023 annual meeting of stockholders, subject to continued service with the Issuer. Read SEC document |
| February 25, 2022 Filed Feb 25, 2022 16:42 UTC |
Minai-Azary Jennifer LynnChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 112,470 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001842952-22-000021 · wf-form4_164582531007999.xml · derivative · entry 1 Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,470 Underlying: Common Stock · 112,470 shares Expires 2032-02-24 F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer. Read SEC document |
| February 25, 2022 Filed Feb 25, 2022 16:43 UTC |
Levit Alex C.Chief Legal Officer, Corp. Sec
|
GrantStock Option (right to buy) · Derivative | 107,870 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001842952-22-000022 · wf-form4_164582536740296.xml · derivative · entry 1 Levit Alex C. · CIK 0001862840 · Chief Legal Officer, Corp. Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,870 Underlying: Common Stock · 107,870 shares Expires 2032-02-24 F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer. Read SEC document |
| February 25, 2022 Filed Feb 25, 2022 16:38 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 254,300 | $0.00 Strike: $1.79 | $0.00 |
DisclosureSEC source: 0001842952-22-000018 · wf-form4_164582507420064.xml · derivative · entry 1 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,300 Underlying: Common Stock · 254,300 shares Expires 2032-02-24 F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 25, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 16:48 UTC |
Rencher William F.Former Section 16 officer
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001842952-22-000014 · wf-form4_164513451665299.xml · derivative · entry 1 Rencher William F. · CIK 0001865206 · Former Section 16 officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2032-02-14 F1 · derivative.exercise_date: The stock option vests in equal installments with 1/10th vesting on the date of this grant and each grant thereafter occurring on the last day of each calendar month until fully vested on October 31, 2022. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 16:56 UTC |
Dick Evan G.Former Section 16 officer
|
GrantStock Option (right to buy) · Derivative | 29,223 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001842952-22-000016 · wf-form4_164513498176142.xml · derivative · entry 1 Dick Evan G. · CIK 0001862116 · Former Section 16 officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,223 Underlying: Common Stock · 0 shares Expires 2032-02-14 F1 · derivative.exercise_date: The stock option vests in equal monthly installments with 1/13th vesting on the last day of the calendar month in which the grant occurs and 1/13th on the last day of each subsequent month until fully vested on February 28, 2023. Additionally, 29,225 previously granted but unvested restricted stock units were cancelled as of December 30, 2021. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 16:02 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
PurchaseCommon Stock | 13,000 | $3.22 | $41,849.60 |
DisclosureSEC source: 0001842952-21-000029 · wf-form4_164003409890044.xml · nonDerivative · entry 1 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 820,190 Read SEC document |
| November 01, 2021 Filed Nov 1, 2021 16:31 UTC |
Minai-Azary Jennifer LynnChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 52,753 | $0.00 Strike: $5.59 | $0.00 |
DisclosureSEC source: 0001842952-21-000009 · wf-form4_163579861906118.xml · derivative · entry 1 Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,753 Underlying: Common Stock · 52,753 shares Expires 2031-11-01 F1 · derivative.exercise_date: The stock option vests each month (1/36 each month) from the date of the grant, November 1, 2021 Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:30 UTC |
Levit Alex C.Chief Legal Officer, Corp. Sec
|
PurchaseCommon Stock | 3,000 | $5.00 | $15,000.00 |
DisclosureSEC source: 0001179110-21-009610 · edgar.xml · nonDerivative · entry 1 Levit Alex C. · CIK 0001862840 · Chief Legal Officer, Corp. Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:29 UTC |
Dick Evan G.SVP of R&D
|
ConversionSeries Seed Preferred Stock · Derivative | 26,587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009608 · edgar.xml · derivative · entry 2 Dick Evan G. · CIK 0001862116 · SVP of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F1 · price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F3 · derivative.exercise_date: Fully vested. F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:29 UTC |
Dick Evan G.SVP of R&D
|
ConversionCommon Stock | 26,587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009608 · edgar.xml · nonDerivative · entry 1 Dick Evan G. · CIK 0001862116 · SVP of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,139 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F2 · balance_after: Includes 39,659 restricted stock units which fully vest on February 24, 2023. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:30 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
ConversionSeries Seed Preferred Stock · Derivative | 586,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009609 · edgar.xml · derivative · entry 7 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 0 Underlying: Common Stock · 586,476 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F3 · price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F2 · derivative.exercise_date: Fully vested. F3 · derivative.expiration_date: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:30 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
ConversionSeries A Preferred Stock · Derivative | 210,722 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009609 · edgar.xml · derivative · entry 6 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 0 Underlying: Common Stock · 210,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F1 · price: Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F2 · derivative.exercise_date: Fully vested. F1 · derivative.expiration_date: Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:30 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
OtherWarrant (right to buy) · Derivative | 52,680 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001179110-21-009609 · edgar.xml · derivative · entry 5 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 0 Underlying: Common Stock · 52,680 shares Expires 2030-12-20 Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:30 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
ConversionCommon Stock | 586,476 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009609 · edgar.xml · nonDerivative · entry 4 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 849,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:30 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
ConversionCommon Stock | 210,722 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-21-009609 · edgar.xml · nonDerivative · entry 3 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 263,402 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:30 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
OtherCommon Stock | 52,680 | $7.14 | $376,135.20 |
DisclosureSEC source: 0001179110-21-009609 · edgar.xml · nonDerivative · entry 2 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 52,680 Read SEC document |
| October 22, 2021 Filed Oct 25, 2021 17:30 UTC |
Lehr Martin A.Director · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $5.00 | $50,000.00 |
DisclosureSEC source: 0001179110-21-009609 · edgar.xml · nonDerivative · entry 1 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,583 Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:12 UTC Amendment |
Dick Evan G.SVP of R&D
|
ConversionSeries Seed Preferred Stock · Derivative | 26,587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001842952-21-000025 · wf-form4a_163977554088927.xml · derivative · entry 2 Dick Evan G. · CIK 0001862116 · SVP of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,587 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F1 · price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F3 · derivative.exercise_date: Fully vested. F1 · derivative.expiration_date: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:12 UTC Amendment |
Dick Evan G.SVP of R&D
|
ConversionCommon Stock | 26,587 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001842952-21-000025 · wf-form4a_163977554088927.xml · nonDerivative · entry 1 Dick Evan G. · CIK 0001862116 · SVP of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F2 · balance_after: Includes 33,397 restricted stock units which fully vest on January 31, 2023. Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:18 UTC Amendment |
Lehr Martin A.Director · Chief Executive Officer
|
ConversionSeries Seed Preferred Stock · Derivative | 586,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001842952-21-000027 · wf-form4a_163977590040895.xml · derivative · entry 8 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 1 Underlying: Common Stock · 586,475 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F2 · price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F3 · derivative.exercise_date: Fully vested. F2 · derivative.expiration_date: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:18 UTC Amendment |
Lehr Martin A.Director · Chief Executive Officer
|
ConversionSeries A Preferred Stock · Derivative | 210,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001842952-21-000027 · wf-form4a_163977590040895.xml · derivative · entry 7 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 7 Underlying: Common Stock · 210,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F1 · price: Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. F3 · derivative.exercise_date: Fully vested. F1 · derivative.expiration_date: Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:18 UTC Amendment |
Lehr Martin A.Director · Chief Executive Officer
|
OtherWarrant (right to buy) · Derivative | 52,680 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001842952-21-000027 · wf-form4a_163977590040895.xml · derivative · entry 6 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 0 Underlying: Common Stock · 52,680 shares Expires 2030-12-20 Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:18 UTC Amendment |
Lehr Martin A.Director · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $5.00 | $50,000.00 |
DisclosureSEC source: 0001842952-21-000027 · wf-form4a_163977590040895.xml · nonDerivative · entry 5 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 807,190 Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:18 UTC Amendment |
Lehr Martin A.Director · Chief Executive Officer
|
ConversionCommon Stock | 586,475 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001842952-21-000027 · wf-form4a_163977590040895.xml · nonDerivative · entry 4 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 797,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:18 UTC Amendment |
Lehr Martin A.Director · Chief Executive Officer
|
ConversionCommon Stock | 210,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001842952-21-000027 · wf-form4a_163977590040895.xml · nonDerivative · entry 3 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 210,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. Read SEC document |
| October 22, 2021 Filed Dec 17, 2021 16:18 UTC Amendment |
Lehr Martin A.Director · Chief Executive Officer
|
OtherCommon Stock | 52,680 | $7.14 | $376,135.20 |
DisclosureSEC source: 0001842952-21-000027 · wf-form4a_163977590040895.xml · nonDerivative · entry 2 Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Martin Lehr 2000 Trust Disclosed balance after: 0 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.